Lazard Asset Management’s MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A MR Stock Holding History

Lazard Asset Management’s Portfolio MR Stock Details MR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-500	Closed	-$13K	–	1171
2015 Q4	$13K	Buy	+500	New	+$12.9K	﹤0.01%	995
2015 Q2	–	Sell	-400	Closed	-$10K	–	1220
2015 Q1	$10K	Hold	400	–	–	﹤0.01%	1058
2014 Q4	$10K	Buy	+400	New	+$11.7K	﹤0.01%	1084
2014 Q1	–	Sell	-965	Closed	-$35K	–	1097
2013 Q4	$35K	Buy	965 +765	+383%	+$29.7K	﹤0.01%	919
2013 Q3	$7K	Buy	+200	New	+$8.06K	﹤0.01%	918

Other funds holding MR

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Lazard Asset Management's MR Position: Q1 2016 in Review

Lazard Asset Management sold out of MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A (MR) in Q1 2016, closing a stake of 500 shares — an estimated $13K sold.

Lazard Asset Management first reported a position in MR in Q3 2013 and held it in 5 quarters. The position peaked at $35K in Q4 2013. 2 funds tracked by Wall St. Rank hold MR as of Q1 2016.

Lazard Asset Management reported no remaining MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A position as of Q1 2016 after selling out during the quarter.
Lazard Asset Management sold 500 MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A shares in Q1 2016, an estimated $13K.
Lazard Asset Management first reported a position in MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A in Q3 2013 and held it in 5 quarters.
Lazard Asset Management's MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A position peaked at $35K in Q4 2013.
2 funds tracked by Wall St. Rank held MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A as of Q1 2016.

Based on Lazard Asset Management's 13F filing for Q1 2016, filed 12 May 2016.